Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Jun 08, 2021 7:00 PM - Jun 11, 2021 12:00 AM

(Central Europe Standard Time)

Future of Evidence and Smart Health Conference

Leveraging RWE to advance healthcare decision-making.

Session 10: What might the future of evidence generation and use look like?

Session Chair(s)

Thomas  Brookland, MSc

Thomas Brookland, MSc

EU Data and AI Policy Lead

F. Hoffmann-La Roche Ltd, Switzerland

Increasing interest and excitement in the potential of health data and evidence within the healthcare community has been triggered by a number of developments, including the greater availability and quality of electronic healthcare information, the emergence of tools for advanced analysis of large data volumes (greater computing power, data handling and analysis techniques) and the ability to link data from multiple sources.

There are a multitude of European initiatives and projects ongoing in this data and evidence generation space, a number of which are being driven by the European Institutions and Regulatory bodies. However, the scope and objectives of these projects often seem to be framed within the next 3 – 5 years, with numerous goals citing 2025 as a target date.

This final session of the workshop will take a look at data and evidence generation a little further into the future and ask what might this space look like in the next 10 – 15 years time and what opportunities, challenges and policy implications may come with this that we should already be thinking about now.

Speaker(s)

Alison  Cave, PhD

Panel Discussion and Q&A

Alison Cave, PhD

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Chief Safety Officer

Cécile Mathilde Ollivier, MS

Contributing Panelist

Cécile Mathilde Ollivier, MS

Critical Path Institute, Netherlands

VP Global Affairs

Irene  Nunes, PhD

Contributing Panelist

Irene Nunes, PhD

Flatiron Health, United States

VP, Head of Regulatory Affairs

Frank  Petavy, MS

Contributing Panelist

Frank Petavy, MS

European Medicines Agency, Netherlands

Head of Methodology

Jesper  Kjær, MS

Contributing Panelist

Jesper Kjær, MS

Novo Nordisk, Denmark

Global Director for Public, Private Partnerships, Strat Ops, Global Med Affairs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.